Cargando…
A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Biomedical Physics and Engineering
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280119/ https://www.ncbi.nlm.nih.gov/pubmed/30568924 |
_version_ | 1783378605844201472 |
---|---|
author | Falahati, F. Nickfarjam, A. Shabani, M. |
author_facet | Falahati, F. Nickfarjam, A. Shabani, M. |
author_sort | Falahati, F. |
collection | PubMed |
description | BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accurate dose is delivered. Today, film dosimetry is a powerful tool for radiotherapy treatment Quality Assurance (QA) and a good method to verify dose distribution in phantoms. OBJECTIVE: This study aimed to evaluate the accuracy of IMRT treatment planning system, Prowess Panther(®) software, with Gafchromic EBT3 films in a inhomogeneity phantom. MATERIAL AND METHODS: The IMRT plan was generated by Prowess Panther(®) treatment planning system (TPS) version 5.2 on a inhomogeneity phantom, then it was irradiated by ONCOR linear accelerator (Linac) with 6 (MV) photon beam energy. The Gafchromic EBT3 film located between the phantom has measured the dose distribution. To compare between TPS calculated doses and film measured doses, Gamma criteria 3%/3 mm, 4%/4 mm, 5%/5 mm, 6%/6 mm and 7%/7 mm Dose Difference (DD) and Distance to Agreement (DTA), respectively were used. RESULTS: Gammas passing rates for PTV are obtained 67.5% for 3%/3mm, 78.8% for 4%/4mm, 86.3% for 5%/5mm, 91.2% for 6%/6mm and 94.3% for 7%/7mm and for organs at risk is 72.4% for 3%/3mm, 82.8% for 4%/4mm, 89.8% for 5%/5mm, 93.3% for 6%/6mm and 95.4% for 7%/7mm (respectively DD/DTA). By increasing the range of criteria the capability increased. CONCLUSION: The results show that the use of EBT3 film in a inhomogeneity phantoms allows us to evaluate the dose differences between the EBT3 measured dose distribution and TPS calculated dose distribution .Hence, a result Prowess Panther(®) TPS can be used for IMRT technique treatment. |
format | Online Article Text |
id | pubmed-6280119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Journal of Biomedical Physics and Engineering |
record_format | MEDLINE/PubMed |
spelling | pubmed-62801192018-12-19 A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film Falahati, F. Nickfarjam, A. Shabani, M. J Biomed Phys Eng Original Article BACKGROUND: Intensity modulated radiation therapy (IMRT) is an advanced method for delivery of three dimensional therapies, which provides optimal dose distribution with giving multiple nonuniform fluency to the patient. The complex dose distribution of IMRT should be checked to ensure that the accurate dose is delivered. Today, film dosimetry is a powerful tool for radiotherapy treatment Quality Assurance (QA) and a good method to verify dose distribution in phantoms. OBJECTIVE: This study aimed to evaluate the accuracy of IMRT treatment planning system, Prowess Panther(®) software, with Gafchromic EBT3 films in a inhomogeneity phantom. MATERIAL AND METHODS: The IMRT plan was generated by Prowess Panther(®) treatment planning system (TPS) version 5.2 on a inhomogeneity phantom, then it was irradiated by ONCOR linear accelerator (Linac) with 6 (MV) photon beam energy. The Gafchromic EBT3 film located between the phantom has measured the dose distribution. To compare between TPS calculated doses and film measured doses, Gamma criteria 3%/3 mm, 4%/4 mm, 5%/5 mm, 6%/6 mm and 7%/7 mm Dose Difference (DD) and Distance to Agreement (DTA), respectively were used. RESULTS: Gammas passing rates for PTV are obtained 67.5% for 3%/3mm, 78.8% for 4%/4mm, 86.3% for 5%/5mm, 91.2% for 6%/6mm and 94.3% for 7%/7mm and for organs at risk is 72.4% for 3%/3mm, 82.8% for 4%/4mm, 89.8% for 5%/5mm, 93.3% for 6%/6mm and 95.4% for 7%/7mm (respectively DD/DTA). By increasing the range of criteria the capability increased. CONCLUSION: The results show that the use of EBT3 film in a inhomogeneity phantoms allows us to evaluate the dose differences between the EBT3 measured dose distribution and TPS calculated dose distribution .Hence, a result Prowess Panther(®) TPS can be used for IMRT technique treatment. Journal of Biomedical Physics and Engineering 2018-12-01 /pmc/articles/PMC6280119/ /pubmed/30568924 Text en Copyright: © Journal of Biomedical Physics and Engineering http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Falahati, F. Nickfarjam, A. Shabani, M. A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film |
title | A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
|
title_full | A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
|
title_fullStr | A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
|
title_full_unstemmed | A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
|
title_short | A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film
|
title_sort | feasibility study of imrt of lung cancer using gafchromic ebt3 film |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280119/ https://www.ncbi.nlm.nih.gov/pubmed/30568924 |
work_keys_str_mv | AT falahatif afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film AT nickfarjama afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film AT shabanim afeasibilitystudyofimrtoflungcancerusinggafchromicebt3film AT falahatif feasibilitystudyofimrtoflungcancerusinggafchromicebt3film AT nickfarjama feasibilitystudyofimrtoflungcancerusinggafchromicebt3film AT shabanim feasibilitystudyofimrtoflungcancerusinggafchromicebt3film |